MindWalk Holdings (HYFT) Deferred Taxes (2023 - 2026)

MindWalk Holdings (HYFT) posted quarterly Deferred Taxes of -$137876.6 for Q2 2026, down 1693.85% quarter-over-quarter from $8650.5 in Q4 2025.

MindWalk Holdings (HYFT) Deferred Taxes (2023 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has reported Deferred Taxes for 4 consecutive years, with -$137876.6 the latest figure, recorded in Q2 2026.

In Q2 2026, Deferred Taxes changed N/A year-over-year to -$137876.6; the TTM figure through Apr 2026 stood at -$129226.1 (up 95.38% YoY), while the FY2026 annual figure was -$129122.6, up 95.43% from the prior year.
Deferred Taxes eased to -$137876.6 in Q2 2026 per HYFT's latest filing, from $8650.5 in the prior quarter.
Across five years, Deferred Taxes topped out at $8650.5 in Q4 2025 and bottomed at -$2.1 million in Q1 2025.
Historically, Deferred Taxes has averaged -$419542.3 across 4 years, with a median of -$191279.8 in 2023.
On a YoY basis, Deferred Taxes climbed as much as 103.58% in 2025 and fell as far as 255.46% in 2025.
MindWalk Holdings' Deferred Taxes stood at -$147498.8 in 2023, then sank by 63.84% to -$241655.3 in 2024, then surged by 103.58% to $8650.5 in 2025, then sank by 1693.85% to -$137876.6 in 2026.
Business Quant data shows HYFT's Deferred Taxes at -$137876.6 in Q2 2026, $8650.5 in Q4 2025, and -$2.1 million in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-69.70 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	194.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-137,876.64
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	2.66 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Roivant Sciences	26.16 Bn	26.85 Bn	1.16 Mn	-

Download Data